Product Information
OFLOXACIN 0.3% EYE DROPS is a generic product labeled by Lifestar Pharma LLC, priced at $1.1136 per ML under NDC 70756065030. Its NADAC has been published 149 times since Nov 29, 2023.
FDA first approved this application on Nov 23, 2022. Its Orange Book therapeutic-equivalence code is AT.
Strength
3 mg/mL
Manufacturer
Lifestar Pharma LLCNDC
70756065030
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
OFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA215886FDA Approved
11/23/2022
TE Code
AT
On Market Since
8/25/2023
Pharmacological Classes
Price Statistics
The NADAC for OFLOXACIN 0.3% EYE DROPS has been published 149 times since Nov 29, 2023, and over the history we have for it it has declined 21.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1136 per ML |
|---|---|
| All-time high | $2.1391 (Feb 14, 2024) |
| All-time low | $0.8360 (Nov 20, 2024) |
| 52-week high | $1.1995 |
| 52-week low | $1.1022 |
| Median price | $1.1995 |
| Average price | $1.3805 |
| Largest weekly change | -43.7% (Nov 20, 2024) |
| Weeks tracked | 149 |
| Tracking since | Nov 29, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lifestar Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ofloxacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OFLOXACIN 0.3% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for OFLOXACIN 0.3% EYE DROPS, manufactured by Lifestar Pharma LLC, is $1.1136 per ML (NDC 70756065030), effective Sep 30, 2026.
How has the price of OFLOXACIN 0.3% EYE DROPS changed over time?
Over the history we have for it, the NADAC for OFLOXACIN 0.3% EYE DROPS has declined 21.3%. It has been tracked across 149 weekly CMS publications since Nov 29, 2023.
What are the highest and lowest recorded NADAC prices for OFLOXACIN 0.3% EYE DROPS?
Since Nov 29, 2023, the NADAC for OFLOXACIN 0.3% EYE DROPS has ranged from a low of $0.8360 (Nov 20, 2024) to a high of $2.1391 (Feb 14, 2024), with a median of $1.1995 per ML.
Are there cheaper alternatives to OFLOXACIN 0.3% EYE DROPS?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OFLOXACIN 0.3% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures OFLOXACIN 0.3% EYE DROPS?
OFLOXACIN 0.3% EYE DROPS (NDC 70756065030) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.